Rajeev Jashnani
Recent Quotes
"JNJ's canagliflozin and Xarelto could add $2.5B in revenues by 2016."
—
Rajeev Jashnani, UBS Securities
(2/21/13)
more >
Due to permission requirements, not all quotes are shown.
"JNJ's canagliflozin and Xarelto could add $2.5B in revenues by 2016."
—
Rajeev Jashnani, UBS Securities
(2/21/13)
more >